This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinicaltrials involving cannabis. Legislation to legalize the medicinal use of marijuana for dogs, cats and other pets in New York State is pending in the Assembly (A. Additionally, a bipartisan coalition of U.S.
The results of our successful pivotal Phase 3 clinicaltrial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Pet Insurance.
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinicaltrial were published in Nature Medicine or profiled on the front page of The New York Times. Team leadership : mentor European study teams in overall regulatory strategy and compliance to enable future patient access expeditiously.
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinicaltrial were published in Nature Medicine or profiled on the front page of The New York Times. Pet Insurance. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit.
Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. What are the benefits of using CBD oil for your pets?…
None of that stopped the FDA from taking the position that CBD is not a supplement, and that it cannot be an ingredient in food and beverages for humans or pets without violating the Food, Drug & Cosmetic Act (“FDCA”). And marketing any bodily or curative effects of CBD was (and still is) off limits. 2018 Farm Bill.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content